- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of biologic therapy in rheumatoid arthritis
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 7, Issue 11, Pages 639-652
Publisher
Springer Nature
Online
2011-10-11
DOI
10.1038/nrrheum.2011.145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
- (2012) Teresa A Simon et al. ARTHRITIS RESEARCH & THERAPY
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
- (2011) K. Au et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
- (2011) Deborah P. M. Symmons et al. Nature Reviews Rheumatology
- Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
- (2011) Wassila Amari et al. RHEUMATOLOGY
- Adverse Cutaneous Reactions Induced by TNF-α Antagonist Therapy
- (2011) Joaquín Borrás-Blasco et al. SOUTHERN MEDICAL JOURNAL
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
- (2010) A. M. Evens et al. ANNALS OF ONCOLOGY
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Pregnancy outcomes after maternal exposure to rituximab
- (2010) E. F. Chakravarty et al. BLOOD
- Safety profile of abatacept in rheumatoid arthritis: A review
- (2010) Majed Khraishi et al. CLINICAL THERAPEUTICS
- The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
- (2010) Joost Frans Swart et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical safety of tocilizumab in rheumatoid arthritis
- (2010) Bernard Bannwarth et al. Expert Opinion On Drug Safety
- A safety assessment of tumor necrosis factor antagonists during pregnancy
- (2010) Vanessa C Osting et al. Expert Opinion On Drug Safety
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2010) Norihiro Nishimoto et al. Modern Rheumatology
- Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis
- (2010) Sing Your Li et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity
- (2009) S. Salemi et al. CLINICAL IMMUNOLOGY
- Dermatological complications and safety of anti-TNF treatments
- (2009) J. F. Kerbleski et al. GUT
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
- (2009) Ann Corken Mackey et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor- Blocker in the Treatment of Rheumatic Diseases
- (2009) Y. J. KIM et al. JOURNAL OF RHEUMATOLOGY
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
- (2009) J. D. CARTER et al. JOURNAL OF RHEUMATOLOGY
- Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
- (2009) R. WESTHOVENS et al. JOURNAL OF RHEUMATOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy?
- (2009) Y. M. ALI et al. JOURNAL OF RHEUMATOLOGY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
- (2008) T A Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
- (2008) M Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
- (2008) J Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
- (2008) N Nishimoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
- (2008) J Askling et al. ANNALS OF THE RHEUMATIC DISEASES
- Immediate Type I Hypersensitivity Response Implicated in Worsening Injection Site Reactions to Adalimumab
- (2008) Michael Paltiel et al. ARCHIVES OF DERMATOLOGY
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) Jonathan Kay et al. ARTHRITIS AND RHEUMATISM
- Inflammatory demyelinating events following treatment with anti-tumor necrosis factor
- (2008) A. Fromont et al. CYTOKINE
- Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study
- (2008) AC Davaine et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy
- (2008) Shunsuke Mori et al. Modern Rheumatology
- Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis
- (2008) L. L. Teichmann et al. RHEUMATOLOGY
- Use of Tumor Necrosis Factor-α Inhibitors in Patients with Chronic Hepatitis B Infection
- (2008) Matthew B. Carroll et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started